Comparison of olanzapine 2.5 mg and 5 mg in the prevention of chemotherapy-induced nausea and vomiting: a Japanese nationwide database study.

Hiroe Suzuki-Chiba Takaaki Konishi Shotaro Aso Kanako Makito Hiroki Matsui Taisuke Jo Kiyohide Fushimi Hideo Yasunaga

Published in: International journal of clinical oncology (2024)

Prophylactic use of olanzapine 2.5 mg during chemotherapy for lung cancer was associated with a higher rate of additional antiemetic drugs than olanzapine 5 mg.

Keyphrases

chemotherapy induced
emergency department
cross sectional
drug induced